title: Effects of EGF receptor ligands on fetal ovine myoblasts.
abstract: Epidermal growth factor (EGF) receptors are widely distributed in mammalian tissues, including muscle. One ligand of these receptors, heparin-binding epidermal growth factor-like growth factor (HB-EGF) is also strongly expressed in adult muscle. However, in vitro studies of EGF action in cultured muscle cells of different species have yielded conflicting results. The purpose of this study was to investigate the potential role of EGF and related factors in the growth and development of fetal ovine muscle. High affinity EGF receptors were detected on clonally purified ovine fetal myoblasts, using [(125)I] human EGF as a ligand (K(d) values of 47 and 54 pM in separate experiments). Competitive binding studies in mixed secondary cultures showed that EGF had the highest affinity for the fetal ovine receptor, followed by HB-EGF and transforming growth factor alpha (TGF-alpha). These ligands all stimulated DNA synthesis in clonally purified ovine myoblasts, with their relative potencies at 0.1 nM reflecting their receptor binding affinities. Maximal effects were seen at 1-10 nM. EGF (10 nM) did not significantly inhibit the differentiation of clonally purified fetal ovine myoblasts, although there was increased proliferation of nondifferentiating cells. Hence a variety of EGF receptor ligands have the potential to influence the proliferation ovine muscle cell precursors in utero, but it is unlikely that they promote differentiation.
authors.affiliation: Division of Nutritional Biochemistry, School of Biosciences, University of Nottingham, Sutton Bonington Campus, Loughborough, Leics LE12 5RD, United Kingdom.
authors.forename: J M
authors.initials: JM
authors.lastname: Harper
authors.forename: P J
authors.initials: PJ
authors.lastname: Buttery
mesh_terms: D000818:Animals; D001667:Binding, Competitive / Q000502:physiology; D002454:Cell Differentiation / Q000502:physiology; D002470:Cell Survival / Q000502:physiology; D002478:Cells, Cultured; D003402:Creatine Kinase / Q000032:analysis; D004247:DNA / Q000032:analysis / Q000096:biosynthesis; D004815:Epidermal Growth Factor / Q000378:metabolism* / Q000502:physiology; D066246:ErbB Receptors / Q000378:metabolism* / Q000502:physiology; D005260:Female; D066257:Heparin-binding EGF-like Growth Factor; D036341:Intercellular Signaling Peptides and Proteins; D007700:Kinetics; D008024:Ligands; D018482:Muscle, Skeletal / Q000166:cytology / Q000196:embryology / Q000378:metabolism* / Q000502:physiology; D011247:Pregnancy; D011897:Random Allocation; D011994:Recombinant Proteins / Q000378:metabolism; D012044:Regression Analysis; D012756:Sheep / Q000196:embryology / Q000378:metabolism*; D016211:Transforming Growth Factor alpha / Q000378:metabolism / Q000502:physiology
chemical_list: C587883:HBEGF protein, human; D066257:Heparin-binding EGF-like Growth Factor; D036341:Intercellular Signaling Peptides and Proteins; D008024:Ligands; D011994:Recombinant Proteins; D016211:Transforming Growth Factor alpha; D004815:Epidermal Growth Factor; D004247:DNA; D066246:ErbB Receptors; D003402:Creatine Kinase